Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Accumulated Expenses (2016 - 2024)

Cavitation Technologies (CVAT) has disclosed Accumulated Expenses for 14 consecutive years, with $434000.0 as the latest value for Q4 2024.

  • Quarterly Accumulated Expenses rose 16.67% to $434000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $434000.0 through Dec 2024, up 16.67% year-over-year, with the annual reading at $414000.0 for FY2024, 47.86% up from the prior year.
  • Accumulated Expenses hit $434000.0 in Q4 2024 for Cavitation Technologies, up from $426000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $889000.0 in Q1 2020 to a low of $280000.0 in Q1 2022.
  • Historically, Accumulated Expenses has averaged $475800.0 across 5 years, with a median of $420000.0 in 2024.
  • Biggest five-year swings in Accumulated Expenses: plummeted 58.02% in 2022 and later surged 47.86% in 2024.
  • Year by year, Accumulated Expenses stood at $667000.0 in 2020, then decreased by 20.69% to $529000.0 in 2021, then tumbled by 47.07% to $280000.0 in 2022, then soared by 32.86% to $372000.0 in 2023, then rose by 16.67% to $434000.0 in 2024.
  • Business Quant data shows Accumulated Expenses for CVAT at $434000.0 in Q4 2024, $426000.0 in Q3 2024, and $414000.0 in Q2 2024.